Ionis Pharmaceuticals (IONS) Debt to Equity: 2009-2025
Historic Debt to Equity for Ionis Pharmaceuticals (IONS) over the last 14 years, with Sep 2025 value amounting to $1.02.
- Ionis Pharmaceuticals' Debt to Equity rose 1421.00% to $1.02 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.02, marking a year-over-year increase of 1421.00%. This contributed to the annual value of $0.09 for FY2024, which is 60.40% down from last year.
- According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Debt to Equity is $1.02, which was up 2.35% from $1.00 recorded in Q2 2025.
- Ionis Pharmaceuticals' 5-year Debt to Equity high stood at $1.02 for Q3 2025, and its period low was $0.02 during Q1 2023.
- Moreover, its 3-year median value for Debt to Equity was $0.16 (2024), whereas its average is $0.34.
- Per our database at Business Quant, Ionis Pharmaceuticals' Debt to Equity plummeted by 83.48% in 2021 and then surged by 1,421.00% in 2025.
- Ionis Pharmaceuticals' Debt to Equity (Quarterly) stood at $0.08 in 2021, then crashed by 65.97% to $0.03 in 2022, then soared by 699.23% to $0.22 in 2023, then crashed by 60.40% to $0.09 in 2024, then soared by 1,421.00% to $1.02 in 2025.
- Its Debt to Equity stands at $1.02 for Q3 2025, versus $1.00 for Q2 2025 and $0.09 for Q4 2024.